Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation

The current study reveals the clinicopathological association of PD-L1 in Hong Kong esophageal squamous cell carcinoma (ESCC) patients and the differential regulation of PD-L1 by standard first-line chemotherapy in ESCC. Immunohistochemical analysis of tissue microarray data from 84 Hong Kong ESCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Hoi Yan, Li, Jian, Tao, Lihua, Lam, Alfred King-Yin, Chan, Kwok Wah, Ko, Josephine Mun Yee, Yu, Valen Zhuoyou, Wong, Michael, Li, Benjamin, Lung, Maria Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122398/
https://www.ncbi.nlm.nih.gov/pubmed/30172884
http://dx.doi.org/10.1016/j.tranon.2018.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122398/
https://www.ncbi.nlm.nih.gov/pubmed/30172884
http://dx.doi.org/10.1016/j.tranon.2018.08.005

Ejemplares similares